Free. Unsubscribe any time.
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. filed 16 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 21 transactions and 106,170 shares. 16 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-07-16, came 9 days after the one before it (2026-07-07) and reports 3 transactions against 4 in the filing before it.
- The sales it reports total 4,351 shares, 1,649 fewer than the 6,000 in the filing before it.
- Its 16 filings on file run from 2026-01-09 to 2026-07-16, and state 4 plan adoption dates, from 2025-05-14 to 2026-03-04.
Trades in Monte Rosa Therapeutics, Inc. 21
- Warmuth Markus — 2026-01-07 · S · 3,707 shares
- Warmuth Markus — 2026-01-07 · S · 1,450 shares
- Warmuth Markus — 2026-01-07 · S · 309 shares
- Warmuth Markus — 2026-03-02 · S · 5,466 shares
- Warmuth Markus — 2026-05-01 · S · 5,467 shares
- Champoux Jennifer — 2026-05-22 · S · 2,176 shares
- Champoux Jennifer — 2026-05-27 · S · 2,175 shares
- Townson Sharon — 2026-05-29 · S · 6,000 shares
- Warmuth Markus — 2026-06-01 · S · 4,998 shares
- Warmuth Markus — 2026-06-01 · S · 468 shares
- Champoux Jennifer — 2026-06-17 · S · 2,176 shares
- Townson Sharon — 2026-06-17 · S · 3,000 shares
Adoption dates in Monte Rosa Therapeutics, Inc. 4
- 2025-05-14 — stated in 4 filings
- 2026-02-19 — stated in 5 filings
- 2026-02-27 — stated in 4 filings
- 2026-03-04 — stated in 3 filings
Results prints in Monte Rosa Therapeutics, Inc. 0
Trades before a print in Monte Rosa Therapeutics, Inc. 0
Interval to Monte Rosa Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 21no later print
Adoption dates Monte Rosa Therapeutics, Inc. states
- 2025-05-14 in 4 filings
- 2026-02-19 in 5 filings
- 2026-02-27 in 4 filings
- 2026-03-04 in 3 filings
Filing text: “10b5-1 trading plan adopted on May 14, 2025”
Sources: SEC EDGAR full-text search and the SEC submissions API.